Octavio Romero, RTICC 2012 Cooperative Research Award in Oncology
News Nov 22, 2012
Octavio Romero, predoctoral researcher at the gene and cancer group at IDIBELL leaded by Dr. Montserrat Sánchez-Céspedes, got the RTICC 2012 research award in oncology, organized by the Thematic Network of Cooperative Research on Cancer (Red Temática de Investigación Cooperativa en Cáncer, RTICC) by the paper entitled “The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer”.
The award was given at the conclusion of the Third Scientific Meeting of Young Researchers RTICC 2012, which took place at the Hospital Vall d'Hebron in Barcelona on 19th and 20th November 2012, and it consisted of a diploma, a memorial object and a prize of 3,000 euros to finance training or candidate's research awarded. The award included an oral presentation of the winning paper at the meeting by the researcher awarded on last 20th November.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Big-Data Analysis Points Toward New Drug Discovery MethodNews
A research team has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.
Changing microRNA's Presence in Glioblastoma Cells Could Change the Tumor's SubtypeNews
BWH researchers examined a specific microRNA, miR-128, to help identify glioblastoma subtypes and to determine if altering the microRNA's presence in glioblastoma cells could change the tumor's subtype.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Techniques for Mammary Gland Research
Mar 05 - Mar 09, 2018